Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

124029 Akt Inhibitor XII, Isozyme-Selective, Akti-2 - Calbiochem

Overview

Replacement Information

Key Spec Table

Empirical Formula
C₃₉H₃₉N₇O₂ • 3HCl

Products

Catalogue NumberPackaging Qty/Pack
124029-2MG Glass bottle 2 mg
Description
OverviewA cell-permeable Akti-1/2- (Cat. No. 124018) derived allosteric inhibitor pair (1:1 regioisomeric mixture) with much improved aqueous solubility (10 mg/ml in a pH 7.4 saline) and Akt2 selectivity (IC50 = 805 nM for Akt2, >10 µM for Akt1/3, and >50 µM for PKA/PKC/SGK). The inhibition is PH domain-dependent and non-competitive with ATP.
Catalogue Number124029
Brand Family Calbiochem®
Synonyms1-((3-(4-((4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)methyl)phenyl)-2-phenyl-6-quinoxalinyl)carbonyl)-4-methyl-piperazine, 3HCl, 1-((2-(4-((4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)methyl)phenyl)-3-phenyl-6-quinoxalinyl)carbonyl)-4-methyl-piperazine, 3HCl and
References
ReferencesZhao, Z., et al. 2008. Bioorg. Med. Chem. Lett. 18, 49.
Product Information
FormYellow solid
Hill FormulaC₃₉H₃₉N₇O₂ • 3HCl
Chemical formulaC₃₉H₃₉N₇O₂ • 3HCl
Hygroscopic Hygroscopic
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
ApplicationAkt Inhibitor XII, Isozyme-Selective, Akti-2, is a cell-permeable, selective inhibitor of Akt2 (IC50 = 805 nM). The inhibition is PH domain-dependent and non-competitive with ATP.
Biological Information
Purity≥97% by HPLC (mixture of regioisomers)
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
124029-2MG 04055977205763

Documentation

Akt Inhibitor XII, Isozyme-Selective, Akti-2 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

Akt Inhibitor XII, Isozyme-Selective, Akti-2 - Calbiochem Certificates of Analysis

TitleLot Number
124029

References

Reference overview
Zhao, Z., et al. 2008. Bioorg. Med. Chem. Lett. 18, 49.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision22-October-2008 RFH
Synonyms1-((3-(4-((4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)methyl)phenyl)-2-phenyl-6-quinoxalinyl)carbonyl)-4-methyl-piperazine, 3HCl, 1-((2-(4-((4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)methyl)phenyl)-3-phenyl-6-quinoxalinyl)carbonyl)-4-methyl-piperazine, 3HCl and
DescriptionA cell-permeable Akti-1/2- (Cat. No. 124018) derived allosteric inhibitor pair (1:1 regioisomeric mixture) with much improved aqueous solubility (10 mg/ml in a pH 7.4 saline) and Akt2 selectivity (IC50 = 805 nM for Akt2, >10 µM for Akt1/3, and >50 µM for PKA/PKC/SGK). The inhibition is PH domain-dependent and non-competitive with ATP.
FormYellow solid
Intert gas (Yes/No) Packaged under inert gas
Chemical formulaC₃₉H₃₉N₇O₂ • 3HCl
Structure formulaStructure formula
Purity≥97% by HPLC (mixture of regioisomers)
SolubilityDMSO (25 mg/ml) or H₂O (50 mg/ml)
Storage Protect from light
+2°C to +8°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesZhao, Z., et al. 2008. Bioorg. Med. Chem. Lett. 18, 49.